Lucid Capital Markets Starts Avalo Therapeutics Inc. (AVTX) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. TENB
6. EBAY
7. CMG
8. KLAC
9. GOOG
10. BIIB

Go back to Lucid Capital Markets Starts Avalo Therapeutics Inc. (AVTX) at Buy

BTIG Starts Avalo Therapeutics Inc. (AVTX) at Buy

December 19, 2024 6:05 AM EST

BTIG analyst Julian Harrison initiates coverage on Avalo Therapeutics Inc. (NASDAQ: AVTX) with a Buy rating and a price target of $40.00.

The analyst comments "We see AVTXs IL-1 mAb AVTX-009 having best-inclass features that could support preferred positioning in several large I&I indications. Lead efforts are in hidradenitis suppurativa, where we continue to expect significant reward for more active Tx options, even after key... More